NSE › Healthcare

Gland Pharma Limited (GLAND)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,579.20+3.05%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹1,743 cr

Revenue YoY

+22.3%

Net profit

₹367 cr

Profit YoY

+96.6%

EPS

₹22.23

EPS estimate

₹15.78

Net margin

21.0%

EPS came in at 22.23 against a street estimate of 15.78 — a beat of 40.9%.

Key statistics

Market cap

₹42,553 cr

P/E

41.4

Forward P/E

51.3

P/B

3.99

Book value

₹628.68

EPS (TTM)

₹62.32

Dividend yield

0.80%

52-week high

₹2,586.00

52-week low

₹1,573.60

50-day MA

₹2,365.31

200-day MA

₹1,928.96

Beta

0.48

Analyst view

with an average price target of ₹2,325.29.

Shareholding

Promoters

51.77%

Institutions

36.28%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Gland Pharma Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.